IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2952 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1555    
    Printed90    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1986  |  Volume : 18  |  Issue : 3  |  Page : 139-143

Effect of ß-adrenoceptor antagonists on tolbutamide induced hypoglycaemia and its half life in rabbits



Correspondence Address:
H Kumar


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

1. Interaction of tolbutamide with some betaadrenoceptor antagonist was studied in normal and alloxan-induced diabetic rabbits. 2. Propranolol and atenolol per se produced hypoglycaemia and potentiated tolbutamide effect also. However, on concurrent administration they failed to influence serum concentration pattern and half life of tolbutamide in normal as well as diabetic rabbits. 3. Metoproiol and acebutolol, both cardio-selective ( blockers, per se neither produced any change in blood sugar level nor influenced tolbutamide hypoglycaemia and its serum level. 4. In diabetic rabbits, all the (adrenergic blockers studied, potentiated tolbutamide hypoglycaemia. 5. In the animals pretreated with (adrenergic blockers for 7days,only propranolol and atenoiol potentiated tolbutamide hypoglycaemia but the serum tolbutamide level remained unchanged.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow